The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
5-Fluorouracil: Forty-Plus and Still Ticking. A Review of its Preclinical and Clinical Development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., Rotman, M., Gershenson, D. M., & Mutch, D. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401501 · Cited by 2,299
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Cooper, J. S., Guo, M. D., Herskovic, A., Macdonald, J. S., Martenson, Jr., Al-Sarraf, M., Byhardt, R., Russell, A. H., Beitler, J. J., Spencer, S., et al. (1999) · JAMA · doi:10.1001/jama.281.17.1623 · Cited by 1,957
Fluorinated pyrimidines, a new class of tumour-inhibitory compounds
HEIDELBERGER, C., CHAUDHURI, N. K., DANNEBERG, P., MOOREN, D., GRIESBACH, L., DUSCHINSKY, R., SCHNITZER, R. J., PLEVEN, E., & SCHEINER, J. (1957) · Nature · doi:10.1038/179663a0 · Cited by 1,603
Bartelink, H., Roelofsen, F., Eschwege, F., Rougier, P., Bosset, J. F., Gonzalez, D. G., Peiffert, D., van Glabbeke, M., & Pierart, M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2040 · Cited by 1,319
(1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.896 · Cited by 1,189
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.301 · Cited by 981
de Gramont, A., Bosset, J. F., Milan, C., Rougier, P., Bouché, O., Etienne, P. L., Morvan, F., Louvet, C., Guillot, T., François, E., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.808 · Cited by 908
Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.
Heggie, G. D., Sommadossi, J., Cross, D. S., Huster, W. J., & Diasio, R. B. (1987) · PubMed · Cited by 722
Lévi, F., Zidani, R., & Misset, J.-L. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03358-8 · Cited by 701
Johnston, P. G., Lenz, H.-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., & Leichman, L. (1995) · PubMed · Cited by 672
Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate
Santi, D. V., McHenry, C. S., & Sommer, H. (1974) · Biochemistry · doi:10.1021/bi00700a012 · Cited by 619
Ensminger, W. D., Rosowsky, A., Raso, V., Levin, D. C., Glodé, M., Come, S. E., Steele, G. D., & Frei, E. (1978) · PubMed · Cited by 521
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3537 · Cited by 495
Leichman, C. G., Lenz, H. J., Leichman, L., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., & Danenberg, P. V. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.10.3223 · Cited by 475
Harris, B., Song, R., Soong, S.-J., & Diasio, R. B. (1990) · PubMed · Cited by 441
Cancer chemotherapy and biotherapy: Principles and practice
Ellis, L. E. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)00005-4 · Cited by 418
Lévi, F. A., Zidani, R., Vannetzel, J.-M., Perpoint, B., Focan, C., Faggiuolo, R., Chollet, P., Garufi, C., Itzhaki, M., Dogliotti, L., et al. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.21.1608 · Cited by 396
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., & Allegra, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8977 · Cited by 382
Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.176 · Cited by 347
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
Sobrero, A. F., Aschele, C., & Bertino, J. R. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.368 · Cited by 336
Stein, B. N., Petrelli, N. J., Douglass, H. O., Driscoll, D. L., Arcangeli, G., & Meropol, N. J. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1<11::aid-cncr2820750104>3.0.co;2-n · Cited by 271
Influence of sex and age on fluorouracil clearance.
Milano, G., Etienne, M. C., Cassuto-Viguier, E., Thyss, A., Santini, J., Frenay, M., Renee, N., Schneider, M., & Demard, F. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1171 · Cited by 260
Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C., & Wataya, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47554-0 · Cited by 252
Tepper, J. E., O'Connell, M. J., Petroni, G. R., Hollis, D., Cooke, E., Benson, A. B., Cummings, B., Gunderson, L. L., Macdonald, J. S., & Martenson, J. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2030 · Cited by 250
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.
Swain, S. M., Lippman, M. E., Egan, E. F., Drake, J. C., Steinberg, S. M., & Allegra, C. J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.890 · Cited by 241
Fisher, T. C., Milner, A. E., Gregory, C. D., Jackman, A. L., Aherne, G. W., Hartley, J. A., Dive, C., & Hickman, J. A. (1993) · PubMed · Cited by 236
Fleming, R. A., Milano, G. A., Thyss, A., Étienne-Grimaldi, M.-C., Renée, N., Schneider, M., & Demard, F. (1992) · PubMed · Cited by 235
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
Rj, F., Baker, L. H., Buroker, T. R., Horwitz, J. P., & Vaitkevicius, V. K. (1980) · PubMed · Cited by 234
宮寺, 和. (1999) · Medical Entomology and Zoology · doi:10.11501/3154225 · Cited by 225
Pritchard, D. M., Watson, A. J. M., Potten, C. S., Jackman, A. L., & Hickman, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1795 · Cited by 198
Rutman, R. J., CANTAROW, A., & Paschkis, K. E. (1954) · PubMed · Cited by 196
Ullman, B., Lee, M., Martin, D. W., & Santi, D. V. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.2.980 · Cited by 196
(1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.960 · Cited by 194
Piedbois, P., Buyse, M. E., Blijham, G. H., et al. (1994) · Journal of Clinical Oncology · Cited by 191
Aschele, C., Sobrero, A. F., Faderan, M. A., & Bertino, J. R. (1992) · PubMed · Cited by 188
Miyadera, K., Sumizawa, T., Haraguchi, M., Yoshida, H., Konstanty, W., Yamada, Y., & Akiyama, S. (1995) · PubMed · Cited by 182
Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
Chu, E., Zinn, S., Boarman, D., & Allegra, C. J. (1990) · PubMed · Cited by 180
Chu, E., & Allegra, C. J. (1993) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-2488-5_16 · Cited by 166
An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug
Ghoshal, K., & Jacob, S. T. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00040-3 · Cited by 164
Curtin, N. J., Harris, A. L., & Aherne, G. W. (1991) · PubMed · doi:10.25405/ncl.34085343 · Cited by 163
Thymineless death in colon carcinoma cells is mediated via Fas signaling
Houghton, J. A., Harwood, F. G., & Tillman, D. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8144 · Cited by 158
van der Wilt, C. L., Pinedo, H. M., Smid, K., & Peters, G. J. (1992) · PubMed · Cited by 118
Hahn, R. G., Moertel, C. G., Schutt, A. J., & Bruckner, H. W. (1975) · Cancer · Cited by 116
Zalcberg, J. R., Kerr, D. J., Seymour, L. W., & Palmer, M. K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00259-7 · Cited by 115
Sommer, H., & Santi, D. V. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90601-9 · Cited by 111
Santi, D. V., & Hardy, L. W. (1987) · Biochemistry · doi:10.1021/bi00400a016 · Cited by 109
Grem, J. L., Hoth, D. F., Hamilton, J. M., King, S. A., & Leyland-Jones, B. (1987) · PubMed · Cited by 109
Self-citationFluorouracil Therapy in Patients With Carcinoma of the Large Bowel
Christophidis, N., Vajda, F. J. E., Lucas, I., et al. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803040-00006 · Cited by 106
Glazer, R. I., & Lloyd, L. S. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14632-4 · Cited by 106
Ghoshal, K., & Jacob, S. T. (1994) · PubMed · Cited by 101
Tillman, D. M., Peták, I., & Houghton, J. A. (1999) · PubMed · Cited by 98
Houghton, J. A., Tillman, D. M., & Harwood, F. G. (1995) · PubMed · Cited by 93
Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
Jl, C., Irwin, L. E., Gj, M., Darvey, H., & BATEMAN, J. R. (1974) · PubMed · Cited by 85
Sobrero, A. F., Aschele, C., Guglielmi, A., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.23.1937 · Cited by 84
Canman, C. E., Lawrence, T. S., Shewach, D. S., Tang, H.-Y. Y., & Maybaum, J. (1993) · PubMed · Cited by 77
Ren, Q., Kao, V., & Grem, J. L. (1998) · PubMed · Cited by 76
Self-citationInteractions of transfer RNA pseudouridine synthases with RNAs substituted with fluorouracil
Samuelsson, T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6139 · Cited by 71
5-Fluorouracil substitution alters pre-mRNA splicing in vitro.
Doong, S.-L., & Dolnick, B. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68949-5 · Cited by 70
Radparvar, S., Houghton, P. J., & Houghton, J. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90046-4 · Cited by 69
Aherne, G. W., Hardcastle, A., Raynaud, F. I., & Jackman, A. L. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00035-4 · Cited by 65
Plasma levels of 5‐fluorouracil after oral and intravenous administration in cancer patients.
Finch, R. R., Bending, M. R., & Lant, A. F. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb04651.x · Cited by 60
Kanamaru, R., Kakuta, H., Sato, T., Ishioka, C., & Wakui, A. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00299864 · Cited by 58
Takimoto, C. H. M., Yee, L., Venzon, D. J., Schüler, B., Grollman, F., Chabuk, C., Hamilton, J. M., Chen, A. P., Allegra, C. J., & Grem, J. L. (1999) · PubMed · Cited by 53
Self-citationMcDermott, B. J., van den Berg, H. W., & Murphy, R. F. (1982) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00257748 · Cited by 53
Patton, J. R. (1993) · Biochemistry · doi:10.1021/bi00085a027 · Cited by 43
Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target
Harris, J. M., McIntosh, E. M., & Muscat, G. E. O. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2680 · Cited by 43
Pharmacokinetic Studies of 5‐Fluorouracil after Oral and Intravenous Administration in Man
Almersjö, O., Gustavsson, B., Regårdh, C. G., et al. (1980) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1980.tb02463.x · Cited by 42
Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells.
Mauro, D. J., de Riel, J. K., Tallarida, R. J., & Sirover, M. A. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13666-3 · Cited by 40
Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy, F., Allegra, C. J., Sinha, B. K., & Grem, J. L. (1994) · PubMed · Cited by 40
Self-citationSchmittgen, T. D., Danenberg, K. D., Horikoshi, T., Lenz, H., & Danenberg, P. V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34003-6 · Cited by 37
Rafi, I., Boddy, A. V., Calvete, J. A., Taylor, G. A., Newell, D. R., Bailey, N. P., Lind, M., Green, M., Hines, J., Johnstone, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1131 · Cited by 37
Wadler, S., Horowitz, R. W., Mao, X., & Schwartz, E. L. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050522 · Cited by 32
Takimoto, C. H. M., Voeller, D. B., Strong, J. M., Anderson, L., Chu, E., & Allegra, C. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36943-1 · Cited by 25
Dihydropyrimidine Dehydrogenase Activity in Human Blood Mononuclear Cells
Tuchman, M., von Roemeling, R., Hrushesky, W. J. M., Sothern, R. B., & O'Dea, R. (2017) · Enzyme · doi:10.1159/000469002 · Cited by 23
5-Fluorouracil suppresses nitric oxide biosynthesis in colon carcinoma cells.
Jin, Y., Heck, D. E., DeGeorge, G. L., Tian, Y., & Laskin, J. D. (1996) · PubMed · Cited by 22
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
5-Fluorouracil: Mechanisms of Resistance and Reversal Strategies
Zhang, N., Yin, Y., Xu, S.-J., & Chen, W.-S. (2008) · Molecules · doi:10.3390/molecules13081551 · Cited by 771
ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Choi, Y., & Yu, A.-M. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282005140214165212 · Cited by 629
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
van Kuilenburg, A. B. P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.004 · Cited by 488
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Metadata
- Authors
- Grem, J. L.
- Venue
- Investigational New Drugs
- Published
- 2000-11
- Volume
- 18
- Issue
- 4
- Pages
- 299-313
- ISSN
- 0167-6997 (ISSN-L)
- 1573-0646
- OpenAlex
- W102725257
- Cited by
- 417
- References
- 80
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.